Awareness of periodontal disease - The role of industry

International Dental Journal

Volumn 48, Issue 3 SUPPL. 1, 1998, Pages 261-267

  Ishikawa, Isao ^a,b   Arakawa, Shinichi ^a  

^a Tokyo Medical and Dental University ^*

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BIOMEDICAL AND DENTAL MATERIALS;

AGED; ANALYTICAL EQUIPMENT; ATTITUDE TO HEALTH; DENTAL EQUIPMENT; DRUG DESIGN; HUMAN; INDUSTRY; MASTICATION; METHODOLOGY; PERIODONTAL DISEASE; PERIODONTICS; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW;

AGED; ANTI-BACTERIAL AGENTS; ATTITUDE TO HEALTH; DENTAL EQUIPMENT; DENTAL MATERIALS; DRUG DESIGN; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; INDUSTRY; MASTICATION; PERIODONTAL DISEASES; QUALITY OF LIFE; REAGENT KITS, DIAGNOSTIC; RECURRENCE;

EID: 0032085974     PISSN: 00206539     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1875-595x.1998.tb00715.x     Document Type: Article

References (68)

1. Slots J, Listgarten M A. Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. J Clin Periodontol 1988 15: 85-93.
2. Dzink J, Socransky S, Haffajee A. The predominant cultivable microbody of active and inactive lesions of destructive periodontal diseases. J Clin Periodontol 1988 15: 316-323.
3. Dzink J, Tanner A, Haffajee A, et al. Gram negative species associated with active destructive periodontal lesions. J Clin Periodontol 1985 12: 648-659
4. Loesche W, Syed S, Schmidt E, et al. Bacterial profiles of subgingival plaques in periodontits. J Periodontol 1985 56: 446-456.
5. Mandell T R. A longitudinal microbiological investigation of Actinobacillus actinomycetemcomitans and Eikenella corrodens in juvenile periodontitis. Infect Immun 1984 45: 778-780.
6. Savitt E, Socransky S. Distribution of certain subgingival microbial species in selected periodontal conditions. J Periodontal Res 1984 19: 111-123.
7. Slots J. Bacterial specificity in adult periodontitis. A summary of recent work. J Clin Periodontol 1986 13: 912-917.
8. Slots J, Bragd L, Wilkstrom M, et al. The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedium in destructive periodontal disease in adults. J Clin Periodontol 1986 13: 570-577.
9. Tanner A, Bouldin H. The microbiology of early periodontitis lesions in adults. J Clin Periodontol 1989 16: 467-471.
10. Slots J, Rains T. New views on periodontal microscopy in special patient categories. J Clin Periodontol 1991 18: 411-420.
11. Bonta Y, Zambon J, Genco R, et al.Rapid identification of periodontal pathogens in subgingival plaque: comparison of indirect immunofluorescence microscopy with bacterial culture for detection of Actinobacillus actinomycetemcomitans. J Dent Res 1985 64: 793-798.
12. Gmur R, Stub J, Guggenheim B. Prevalence of Bacteroides forsythus and Bacteroides gingivalis in subgingival plaque of prosthodontically treated patients on short recall. J Peridont Res 1989 24: 113-120.
13. 2 laser in the excision of gingival hyperlasia caused by nifedipine. J Clin Periodontol 1988 15: 633-635.
14. 2 laser for gingivectomy in a patient with Sturge-Weber disease complicated by dilantin hyperplasia. J Oral Maxillofac Surg 1986 44: 646-648.
15. Meyers T D, Murphy D G, White J M, et al. Conservative soft tissue management with the low-powered pulsed Nd: YAG dental laser. Pract Periodontics Aesthetic Dent 1992 4: 6-12.
16. Midda M, Renton-Harper P. Lasers in dentistry. Br Dent J 1991 170: 343-346.
17. 2 laser in oral and maxillofacial surgery. J Oral Maxillofac Surg 1983 41: 725-728.
18. 2 laser in soft tissue dental surgery. Laser Surg Med 1987 7: 207-213.
19. Pick P M, Pecaro B C, Silberman C J. The laser gingivectomy. The use of the CO, laser for the removal of phenytoin hyperplasia. J Periodontol 1985 56: 492-496.
20. Roed-Petersen B. The potential use of CO, laser gingivectomy for phenytoin-induced gingival hyperplasia in mentally retarded patients. J Clin Periodontol 1993 20: 729-731.
21. White J M, Goodis H E, Rose C L. Use of the pulsed Nd: YAG laser for intraoral soft tissue surgery. Laser Surg Med 1991 11: 455-461.
22. Aoki A, Ando Y, Watanabe H, et al. In vitro studies on laser scaling of subgingival calculus with an Erbium: YAG laser J Periodontol 1994 65: 1097-1106.
23. Ando Y, Aoki A, Ishikawa I. Bactericidal effect of Erbium: YAG laser on periodontopathic bacteria. Lasers Surg Med 1996 19: 190-200.
24. Alexander M B, Damoulis, P D. The role of cytokines in the pathogenesis of periodontal disease. Current Opin Periodontol 1994 39: 39-53.
25. Giannobile W V, Finkelman R D, Lynch S E. Comparison of canine and non-human primate animal models for periodontal regenerative therapy: results following a single administration of PDGF/IGF-I. J Periodontol 1994 65: 1158-1168.
26. Howell, T, H., Martuscelli, G, Oringer, J. Polypeptide growth factors for periodontal regeneration. Current Opin Periodontol 1996 3: 149-156.
27. Kubota K, Yoshimura N, Yokota M, et al. Overview of effects of electrical stimulation on osteogenesis and alveolar bone. J Periodontol 1995 66: 2-6.
28. Lynch S E, de C G, Williams R C, et al. The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol 1991 62: 458-467.
29. Mundy G R. Cytokines and growth factors in the regulation of bone remodelling. J Bone Mineral Res 1993 8: S505-510.
30. Page R C. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Perio Res 1991 26: 230-242.
31. Reynolds J J, Hembry R M, Meikle M C. Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv Dent Res 1994 8: 312-319.
32. Sodek J, Overall C M. Matrix metalloproteinases in periodontal tissue remodelling. Matrix Suppl 1992 1: 352-362.
33. Williams R C, Beck J D, Offenbacher S N. The impact of new technologies to diagnose and treat periodontal disease. A look to the future. J Clin Periodontol 1996 23: 299-305.
34. Wozney, J M. The potential role of bone morphogenetic proteins in periodontal reconstruction. J Periodontol 1995 66: 506-510.
35. Kinoshita A, Oda S, Takahashi K et al. Periodontal regeneration by application of recombinant human bone morphogenic protein-2 to horizontal circumferential defects created by experimental periodontits in beagle dogs J Periodontol 1997 68: 103-109.
36. Catalano S J, Palmon A, Burstein Y, et al. Amino acid sequence of a major human amelogenin protein employing Edman degradation and cDNA sequencing. J Dent Res 1993 72: 1566-1572.
37. Calalano S J, laskov R, Palmon A, et al. Production of a monoclonal antibody against human amelogenin. Calci Tissue Internat 1994 54: 76-80.
38. Deutsch D, Palmon A, Catalano S J, et al. Production of monoclonal antibodies against enamelin and against amelogenin proteins of developing enamel matrix. Adv Dent Res 1987 1: 282-288.
39. Deutsch D. Structure and function of enamel gene products. Anat Rec 1989 224: 189-210.
40. Deutsch D, Catalano SJ, Dafni I, et al. Enamel matrix proteins and ameloblast biology. Connec Tissue Res 1995 32: 97-107.
41. Pontortero R, Lindhe J, Nyman S, et al. Guided tissue regeneration in degree II furcation-involved mandibular molars. A clinical study. J Clin Periodontol 1988 15: 247-254.
42. Becker W, Becker B E, Berg L, et al. New attachment after treatment with root isolation procedures: report of treated class III and class II furcations and vertical osseous defects. Int J Periodont Rest Dent 1988 8: 8-23.
43. Caffesse R G, Smith B A, Duff B, et al. Class II furcations treated by guided tissue regeneration in humans: Case reports J Periodontol 1990 61: 510-514.
44. Blunmenthal N M. The use of collagen membranes to guide regeneration of new connective tissue attachment in dogs. J Periodontol 1988 59: 830-836.
45. Caffesse R G, Nasijleti C E, Morrison E C, et al. Guided tissue regeneration: comparison of bioabsorbable and non-bioabsorbable membranes. Histologic and histometric study in dogs. J Periodontol 1994 65: 583-591.
46. Card S J, Caffesse R G, Smith B A,et al. New attachment following the use of a resorbable membrane in the treatment of periodontitis in dogs. Int J Periodont Rest Dent 1989 9: 59-69.
47. Minabe M, Kodama T, Kogou T, et al. Different cross-linking types of collagen materials implanted in rat Palatal gingiva. J Periodontol 1989 60: 35-43.
48. Grossman E, Meckel A H, Isaacs R L et al. A clinical comparison of antibacterial mouthrinses: effects of chlorhexidine, phenolic, and sanguinarine on dental plaque and gingivitis. J Periodontol 1989 60: 435-440.
49. Siegrist B E, Gusberti F A, Brecx M C, et al. Efficacy of supervised rinsing with chlorhexidine digluconate in comparison to phenolic and plant alkaloid compounds. J Periodont Res 1986 21: 60-73.
50. Lamkin M S, Oppenheim F G. Structural features of salivary function. Critic Rev in Oral Biol Med 1993 4: 251-259.
51. Asikainen S, Jousimies-Somer H, Kanervo A,et al. The immediate efficacy of adjunctive doxycycline in treatment of localised juvenile periodontitis. Arch oral Biol 1990 35: 231S-234S.
52. Gordon J, Walker C, Houliaras C, et al. Efficacy of clindamycin hydrochloride in refractory periodontitis: 24-month results. J Periodontol 1990 61: 686-691.
53. Jenkins WMM, MacFarlane T W, Gilmour W H, et al. Systemic metronidazole in the treatment of periodontitis. J Clin Periodontol 1989 16: 443-450.
54. Magnusson I, Clark W B, Low S B, et al. Effect on non-surgical periodontal therapy combined with adjunctive antibiotics in subjects with "refractory" periodontal disease. 1. Clinical results. J Clin Periodontol 1989 16: 647-653.
55. Matisko M W, Bissada N F. Short-term sequential administration of amoxicillin/clavulanate potassium and doxycycline in the treatment of recurrent/progressive periodontitis. J Periodontol 1993 64: 553-558.
56. Novak M N, Stamatelakys C, Adair S M. Resolution of early lesions of juvenile periodontitis with tetracycline therapy alone: long-term observations of 4 cases. J Periodontol 1991 62: 628-633.
57. Soder P O, Frithiof L, Wikner S, et al. The effect of systemic metronidazole after non-surgical treatment in moderate and advanced periodontitis in young adults. J Periodontol 1990 61: 281-288.
58. van Winkelhoff A J, Tijhof C J, de Graaff J. Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis. J Periodontol 1992 63: 52-57.
59. Goodson J M. Antimicrobial strategies for treatment of periodontal diseases. Periodontol 2000 1994 5: 142-168.
60. Eckles T A, Reinhardt R A, Dyer J K, et al. Intracrevicular application of tetracycline in white petrolatum for the treatment of periodontal disease. J Clin Periodontol 1990 17: 454-462.
61. Goodson JM, Cugini MA, Kent RL, et al. Multicenter evaluation of tetracycline fibre therapy. II. Clinical response. J Periodont Res 1991 26: 371-379.
62. Kimura S, Toda H, Shimabukuro Y, et al. Topical chemotherapy in human periodontitis using a new controlled-release insert containing ofloxacin. I. Microbiological observation. J Periodontol 1991 26: 33-41.
63. Lazzaro A J, Bissada N F. Clinical and microbiologic changes following the irrigation of periodontal pockets with metronidazole or stannous fluoride. Perio Case Rep 1989 11: 12-19.
64. Minabe M, Takeuchi K, Nishimura T, et al. Therapeutic effects of combined treatment using tetracycline-immobilized collagen film and root planing in periodontal furcation pockets. J Clin Periodontol 1991 18: 287-290.
65. Okuda K, Wolff L, Oliver R, et al. Minocycline slow-release formulation effect on subgingival bacterial. J Periodontol 1992 63: 73-79.
66. Rapley J W, Cobb C M, Killoy W J, Williams D R. Serum levels of tetracycline during treatment with tetracycline containing fibres. J Periodontol 1992 63: 817-820.
67. Pourtaghi N, Radvar M, Mooney J, et al. The effect of subgingival antimicrobial therapy on the levels of stromelysin and tissue inhibitor of metalloproteinases in gingival crevicular fluid. J Periodontol 1996 67: 866-870.
68. Sorsa T, Konttinen Y T, Lindy O, et al. Doxycycline protects serum alpha-1-antitrypsin from human neutrophil collagenase. Agen Act Supple. 1993 39: 225-229.